Document ID: chunk:federal_register_of_legislation:F2024L00485:reg:9:p1
Version: federal_register_of_legislation:F2024L00485
Segment Type: reg
Provision Reference: reg 9 (pt 1/2)
Character Range: 4206–7246

9               Factors that must exist
At least one of the following factors must as a minimum exist before it can be said that a reasonable hypothesis has been raised connecting malignant melanoma of the skin or death from malignant melanoma of the skin with the circumstances of a person's relevant service:
(1)          having at least 5 sunburns at the affected site at least 2 years before  clinical onset;
Note: sunburn and clinical onset are defined in the Schedule 1 - Dictionary.
(2)          having a burn scar involving the affected site at least 5 years before clinical onset;
(3)          having sunlight exposure to unprotected skin for a cumulative period of at least 2,250 latitude equivalent hours before clinical onset;
Note: latitude equivalent hours and unprotected skin are defined in the Schedule 1 - Dictionary.
(4)          having ultraviolet radiation exposure from an ultraviolet-emitting tanning device on at least 5 occasions before the clinical onset of malignant melanoma of the skin, where the first exposure occurred more than 2 years before clinical onset;
(5)          having PUVA therapy, where:
(a)          the first PUVA treatment commenced at least 10 years before clinical onset; and
(b)          at least 200 PUVA treatments were administered, before clinical onset;
Note: PUVA therapy is defined in the Schedule 1 - Dictionary.
(6)          undergoing solid organ (excluding corneal transplant) or bone marrow transplantation before clinical onset;
(7)          being treated with methotrexate or azathioprine within the 5 years before clinical;
(8)          being infected with human immunodeficiency virus before clinical onset;
(9)          having non-Hodgkin lymphoma at least one year before clinical onset;
(10)      having chronic lymphocytic leukaemia/small cell lymphoma at least one year before clinical onset;
Note: Chronic lymphocytic leukaemia/small cell lymphoma is also known as mature B-cell lymphoid leukaemia and small lymphocytic lymphoma.
(11)      having Parkinson's disease for at least 2 years before clinical onset;
(12)      for superficial spreading melanoma only, taking oral estradiol menopausal hormone therapy continuously for at least 6 months, more than 2 years before clinical onset;
(13)      taking voriconazole continuously for at least 1 year, more than 3 years before clinical onset;
(14)      being obese for at least 5 years within the 20 years before clinical onset;
Note: being obese is defined in the Schedule 1 – Dictionary.
(15)      consuming at least 30 grams of alcohol per day for at least one year, more than 5 years before clinical onset;
(16)      being employed as a firefighter for a cumulative period of at least 10 years, more than 5 years before clinical onset;
(17)      inhaling, ingesting or having cutaneous contact with dielectric (insulating) liquids containing polychlorinated biphenyls during the production or repair of capacitors, transformers, or electrical switches, for a cumulative period of at least 2,000 hours, completed at